Recurrent Undifferentiated Pleomorphic Sarcoma
4 clinical trials · Condition
◉ Watch Recurrent Undifferentiated Pleomorphic Sarcoma
| Record | Firm | Date |
|---|---|---|
| Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study (NCT05017103) | M.D. Anderson Cancer Center | 2021-07-13 |
| Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery (NCT03307616) | M.D. Anderson Cancer Center | 2017-10-04 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma (NCT02601209) | National Cancer Institute (NCI) | 2015-11-30 |
| Alisertib in Treating Patients With Advanced or Metastatic Sarcoma (NCT01653028) | National Cancer Institute (NCI) | 2012-08-22 |
Track Recurrent Undifferentiated Pleomorphic Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.